Article

The RARRES1-RUNX3-HEXB Axis Drives Lipogenic Reprogramming and Tumor Progression in Glioblastoma

2026-06-24

Abstract excerpt

<title>Abstract</title> <p>Background Glioblastoma (GBM) is a highly malignant intracranial tumor with limited therapeutic strategies. Aberrant metabolic reprogramming is a hallmark of GBM malignancy, yet the upstream transcriptional regulatory networks driving lipid anabolism remain incompletely defined. Methods Clinical specimen analysis was performed to assess RARRES1 expression and its correlation with tumo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8adb5248-334e-5ed4-9ed3-5c872ea5bc26
DOI: 10.21203/rs.3.rs-10051500/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The RARRES1-RUNX3-HEXB Axis Drives Lipogenic Reprogramming and Tumor Progression in GlioblastomaDOI 10.21203/rs.3.rs-10051500/v1Read

Lipid Metabolism classification of gliomasSemantic proximity Read

Exploration of prognosis and immune infiltration characteristics in Glioblastoma Multiforme based on Lipid Metabolism related GenesSemantic proximity Read

Autophagy–Cholesterol Axis Remodeling Supports Malignant Progression and Chemoresistance in GliomaSemantic proximity Read

LXRβ controls glioblastoma cell growth, lipid balance, and immune modulation independently of ABCA1Semantic proximity Read

Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastomaSemantic proximity Read

Augmented expression of RUNX1 deregulates the global gene expression of U87 glioblastoma multiforme cells and inhibits tumor growth in miceSemantic proximity Read

Current Research Trends in GBM: Focus on the RTKsSemantic proximity Read

miR-18a promotes glioblastoma development by down-regulating ALOXE3-mediated ferroptotic and anti-migration activitiesSemantic proximity Read

IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axisSemantic proximity Read

FXYD5 promotes the growth of glioblastoma by targeting the PI3K/AKT/ACSL4 signaling axisSemantic proximity Read

Nuclear receptor LXR as a novel therapeutic antitumoral target in glioblastoma.Semantic proximity Read

Survival-Associated Differentially Expressed Alternative Splicing Signatures Reveal Neuron Signaling and Metabolism-Related Processes in GlioblastomaSemantic proximity Read